These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 13959)
21. CSF and urine biogenic amine metabolites in Rett syndrome. Lekman A; Witt-Engerström I; Holmberg B; Percy A; Svennerholm L; Hagberg B Clin Genet; 1990 Mar; 37(3):173-8. PubMed ID: 1691058 [TBL] [Abstract][Full Text] [Related]
22. Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs. Faull KF; Barchas JD; Foutz AS; Dement WC; Holman RB Brain Res; 1982 Jun; 242(1):137-43. PubMed ID: 6179569 [TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid (CSF) and brain monoamine metabolites in the developing rat pup. Shaywitz BA; Anderson GM; Cohen DJ Brain Res; 1985 Jan; 349(1-2):225-32. PubMed ID: 2580600 [TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Legangneux E; Mora JJ; Spreux-Varoquaux O; Thorin I; Herrou M; Alvado G; Gomeni C Rheumatology (Oxford); 2001 Mar; 40(3):290-6. PubMed ID: 11285376 [TBL] [Abstract][Full Text] [Related]
25. Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. Blennow K; Wallin A; Gottfries CG; Månsson JE; Svennerholm L J Neural Transm Park Dis Dement Sect; 1993; 5(1):5-15. PubMed ID: 7679905 [TBL] [Abstract][Full Text] [Related]
26. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid. Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912 [TBL] [Abstract][Full Text] [Related]
27. Psychic disturbances in adult coeliac disease. III. Reduced central monoamine metabolism and signs of depression. Hallert C; Aström J; Sedvall G Scand J Gastroenterol; 1982 Jan; 17(1):25-8. PubMed ID: 6182605 [TBL] [Abstract][Full Text] [Related]
28. Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone. Garrick NA; Seppala T; Linnoila M; Murphy DL Psychopharmacology (Berl); 1985; 86(3):265-9. PubMed ID: 2412251 [TBL] [Abstract][Full Text] [Related]
29. Analysis of equine cisterna magna cerebrospinal fluid for the presence of some monoamine neurotransmitters and transmitter metabolites. Vaughn DM; Smyth GB; Whitmer WL; Satjawatcharaphong C Vet Res Commun; 1989; 13(3):237-49. PubMed ID: 2476887 [TBL] [Abstract][Full Text] [Related]
30. Changes of serotonin and catecholamines are related to pharmacokinetic alterations of clomipramine in rat brain. Fujita K; Kobayashi A; Suzuki S; Nakazawa K Eur J Pharmacol; 1991 Nov; 204(3):227-33. PubMed ID: 1723048 [TBL] [Abstract][Full Text] [Related]
31. Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding. Asberg M; Wägner A Ciba Found Symp; 1986; 123():57-83. PubMed ID: 2434288 [TBL] [Abstract][Full Text] [Related]
32. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071 [TBL] [Abstract][Full Text] [Related]
33. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment. Beckmann H; Waldmeier P; Lauber J; Gattaz WF J Neural Transm; 1983; 57(1-2):103-10. PubMed ID: 6194254 [TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia. Roy A; Pickar D; Linnoila M; Doran AR; Ninan P; Paul SM Psychiatry Res; 1985 Aug; 15(4):281-92. PubMed ID: 2415996 [TBL] [Abstract][Full Text] [Related]
35. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease. Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850 [TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Eriksson E; Alling C; Andersch B; Andersson K; Berggren U Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413 [TBL] [Abstract][Full Text] [Related]
37. High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma. Seegal RF; Brosch KO; Bush B J Chromatogr; 1986 Apr; 377():131-44. PubMed ID: 2423546 [TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression. Fu R; Jinnah H; Mckay JL; Miller AH; Felger JC; Farber EW; Sharma S; Whicker N; Moore RC; Franklin D; Letendre SL; Anderson AM J Neurovirol; 2023 Aug; 29(4):440-448. PubMed ID: 37289360 [TBL] [Abstract][Full Text] [Related]
39. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040 [TBL] [Abstract][Full Text] [Related]